Posted in | News | Fibre Optics

Net Optics Introduces 40G Monitoring Access Solution for High-Performance Networks

Net Optics, Inc., the global leader in intelligent network access solutions, today announced a new 40G fiber Tap for high-performance networks.  Net Optics now provides organizations with a flexible 40G monitoring access solution that can be deployed across the entire network infrastructure to improve network and application performance, increase IT staff efficiency and reduce business risk.  The new 40G Tap provides customers with investment protection and ensures a smooth transition from 10G to 40G networks.

The all-optical design of the 40G Fiber Tap is optimized and tested for high-performance fiber networks.  Requiring no power, the fiber Taps maintain permanent passive access ports without introducing a point of failure or disturbing other network connections.  These passive Taps deliver full-duplex monitoring with zero impact on network traffic around the clock.  Full-duplex monitoring is a simplified with a custom monitoring cable that sends each side of the signal to a separate NIC on the monitoring device.  Without an IP address, monitoring devices are isolated from the network, dramatically reducing their exposure to attacks.  However, the monitoring device connected to the Tap still sees all full-duplex traffic as if it were in-line, including Layer 1 and Layer 2 errors.

“Our customers rely on Net Optics monitoring access solutions to ensure the long term health and performance of their business-critical networks,” said Bob Shaw, president and CEO of Net Optics.  “Many of our largest customers are already looking ahead to 40 Gigabit network deployments, and Net Optics is providing long-term investment protection in our current line of products.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.